Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.47 |
| ▸ | FTO | Q9C0B1 | 8/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.46 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3730178 | 0.87 | FTO (0.59) | HPGDALDH1A1HSD17B10CYP2C9ALOX15 | |
| SCHEMBL2371477 | 0.82 | FTO (0.70) | HPGDALDH1A1HSD17B10CYP2C9ALOX15 | |
| SCHEMBL5697654 | 0.79 | HPGD (0.51) | HPGDALDH1A1HSD17B10CYP2C9ALOX15 | |
| SCHEMBL20832 | 0.79 | ALDH1A1 (0.60) | HPGDALDH1A1HSD17B10CYP2C9ALOX15 | |
| SCHEMBL2371404 | 0.78 | HPGD (0.52) | HPGDALDH1A1HSD17B10CYP2C9ALOX15 | |
| SCHEMBL6652238 | 0.78 | HPGD (0.47) | HPGDALDH1A1HSD17B10CYP2C9ALOX15 | |
| SCHEMBL991486 | 0.78 | MAPT (0.61) | HPGDALDH1A1HSD17B10CYP2C9ALOX15 | |
| SCHEMBL15902813 | 0.78 | FTO (0.55) | HPGDALDH1A1HSD17B10CYP2C9ALOX15 | |
| SCHEMBL312455 | 0.78 | FTO (0.55) | HPGDALDH1A1HSD17B10CYP2C9ALOX15 | |
| SCHEMBL9871326 | 0.77 | FTO (0.56) | HPGDALDH1A1HSD17B10CYP2C9ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12105092-B2 | Molecularly imprinted particles | GEORGE MASON UNIVERSITY (US) | 2024-10-01 | — | — | US | claimed |
| US-12558448-B2 | Immobilized pH indicator for biological indicator growth indication | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2026-02-24 | — | — | US | disclosed |
| US-12228555-B2 | Self-contained biological indicator | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-02-18 | — | — | US | disclosed |
| US-12105092-B2 | Molecularly imprinted particles | GEORGE MASON UNIVERSITY (US) | 2024-10-01 | — | — | US | disclosed |
| US-20230313261-A1 | Biological Indicator Comprising Genetically-Modified Test Microorganism | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2023-10-05 | — | — | US | disclosed |
| US-20230193347-A1 | Biological Indicator with Test Microorganisms Enveloped by Wax Composition | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2023-06-22 | — | — | US | disclosed |
| US-20230110772-A1 | Immobilized pH Indicator for Biological Indicator Growth Indication | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2023-04-13 | — | — | US | disclosed |
| US-20230047207-A1 | Self-Contained Biological Indicator with Salt Compound | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2023-02-16 | — | — | US | disclosed |
| US-20210311002-A1 | SELF-CONTAINED BIOLOGICAL INDICATOR | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-10-07 | — | — | US | disclosed |
| WO-2021148909-A1 | SELF-CONTAINED BIOLOGICAL INDICATOR WITH SALT COMPOUND | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-07-29 | — | — | WO | disclosed |
| US-20200385776-A1 | COMPOSITIONS AND METHODS TO DETECT MICROORGNAISMS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2020-12-10 | — | — | US | disclosed |
| US-20200363421-A1 | MOLECULARLY IMPRINTED PARTICLES | GEORGE MASON UNIVERSITY (US) | 2020-11-19 | — | — | US | disclosed |
| US-20160008783-A1 | PHOTOCATALYTIC DEGRADATION OF SUGAR | EMPIRE TECHNOLOGY DEVELOPMENT LLC | 2016-01-14 | — | — | US | disclosed |
| US-20140162309-A1 | Arsenical Fluorescent Agents and Assays | SRI INTERNATIONAL (US) | 2014-06-12 | — | — | US | disclosed |
| US-8664009-B2 | Arsenical fluorescent agents and assays | SRI INTERNATIONAL (US) | 2014-03-04 | — | — | US | disclosed |
| US-20110229929-A1 | Arsenical Fluorescent Agents and Assays | SRI INTERNATIONAL | 2011-09-22 | — | — | US | disclosed |
| US-20100047859-A1 | SILICA-BASED FLUORESCENT NANOPARTICLES | SNU R&DB FOUNDATION (KR) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12558448-B2 | Immobilized pH indicator for biological indicator growth indication | ALPG, GUSB, HAO2 | HPGD 740/4885ALDH1A1 291/4885HSD17B10 98/4885 |
| US-20110229929-A1 | Arsenical Fluorescent Agents and Assays | AS3MT, ANXA5, ARSA | HPGD 3250/4885ALDH1A1 77/4885HSD17B10 3312/4885 |
| US-20100047859-A1 | SILICA-BASED FLUORESCENT NANOPARTICLES | NOXO1, NOX3, SOS1 | HPGD 3258/4885ALDH1A1 1247/4885HSD17B10 2638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.